Stocktoria
Solventum Corp SOLV
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2024-03-26
Solventum Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Gross margin | 53.5% | 55.6% | 57.3% |
| Operating margin | 26.2% | 12.6% | 20.6% |
| Net margin | 18.7% | 5.8% | 16.4% |
| FCF margin | -0.1% | 9.8% | 19.8% |
| Return on assets | 10.9% | 3.3% | 9.7% |
| Return on equity | 30.8% | 16.2% | 11.5% |
| Debt / equity | 1.00× | 2.71× | 0.00× |
| Current ratio | 1.23 | 1.20 | 1.46 |
| Revenue growth | 0.9% | 0.7% | — |
Source: SEC EDGAR filings · CIK 0001964738 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.